Thus, the N-cadherin block is an optimal therapy because it disrupts PD-L1 and IDO-1 expression and abrogates the immunosuppressive effect elicited by IFN-γ pathways that are active in the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.